Eric Bjerkholt

Mr. Eric H.
Bjerkholt is an Independent Director at Metagenomi Therapeutics, Inc., a Chief Financial Officer at Mirum Pharmaceuticals, Inc., an Independent Director at Surrozen, Inc. and an Independent Director at Cerus Corp.
He is on the Board of Directors at Metagenomi Therapeutics, Inc., Surrozen, Inc., Cerus Corp.
and Aimmune Therapeutics UK Ltd. Mr. Bjerkholt was previously employed as an Independent Director by CalciMedica, Inc., a Chief Financial Officer by Chinook Therapeutics, Inc., an Independent Director by Graybug Vision, Inc., a Chief Financial Officer by Aimmune Therapeutics, Inc., an Independent Director by Ambrx, Inc., an Independent Director by StemCells, Inc., a CFO, Secretary & EVP-Corporate Development by Sunesis Pharmaceuticals, Inc., a Chief Financial Officer & Senior Vice President by IntraBiotics Pharmaceuticals, Inc., a President, Chief Executive & Financial Officer by Kenady LLC, and a Vice President by J.P.
Morgan & Co., Inc. (Delaware).
He also served on the board at Corium Inc., Atara Biotherapeutics, Inc., Round Table Pizza, Inc. and Structure Therapeutics, Inc. He received his undergraduate degree from the University of Oslo and an MBA from Harvard Business School.